FBRX Stock On Track For Highest Levels In Over 4.5 Years As ArgenX Scoops Up Autoimmune Drug Maker

ArgenX is acquiring Forte Biosciences, an autoimmune drug maker.

FBRX stock is on track for highest levels in over 4.5 years.

The acquisition will add to ArgenX's immunology portfolio.

ArgenX already has therapies for autoimmune and neuromuscular diseases.